[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595418":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":22,"responsibleParty":43,"collaborators":10,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":47,"sex":53,"minAge":54,"maxAge":10,"enrollmentInfo":55,"targetDuration":10,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":62,"overallStatus":25,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Fondazione del Piemonte per l'Oncologia","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Da Vinci SP Robotic Surgery Cohort",null,"This cohort includes all patients undergoing urologic surgical procedures using the Da Vinci Single Port (SP) robotic platform at IRCCS Candiolo. The procedures may include radical prostatectomy, partial or radical nephrectomy, adenomectomy, and nephroureterectomy. All surgeries are performed through a single surgical incision using the SP system, without additional experimental interventions. The outcomes of this cohort will be observed prospectively, and perioperative, functional, and oncologic results will be analyzed. Exploratory comparisons may be made with outcomes from historical or contemporaneous multiport (Da Vinci Xi) procedures",[13,18],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Enrico Checcucci, MD","CONTACT","00390119933623","enrico.checcucci@ircc.it",{"name":19,"role":15,"phone":20,"phoneExt":10,"email":21},"Annamaria Nuzzo, PHD","00390119933844","annamaria.nuzzo@ircc.it",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Fondazione del Piemonte per l'Oncologia- IRCCS Istituto di Candiolo","RECRUITING","Candiolo","Turin","10060","Italy","IT",{"type":32,"coordinates":33},"Point",[34,35],7.59812,44.95858,{"lat":35,"lon":34},[38,39,41],{"name":19,"role":15,"phone":20,"phoneExt":10,"email":21},{"name":14,"role":15,"phone":40,"phoneExt":10,"email":17},"00390119933632",{"name":14,"role":42,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":44,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100595418","prospective-study-on-the-use-of-the-da-vinci-sp-system-in-urological-surgery-100595418",false,"NCT07032194","Prospective Study on the Use of the Da Vinci SP System in Urological Surgery","Use of the Da Vinci Single Port Robotic System in Urological Surgery: A Prospective Observational Study (SP-URO)","SP-URO","Inclusion Criteria:\n\n* Signed informed consent and data privacy consent\n* Clinical indication for urologic robotic surgery per EAU guidelines or clinical trial eligibility\n* ECOG Performance Status 0-1\n* Life expectancy ≥ 10 years\n* Availability of preoperative clinical data\n* Willingness to comply with follow-up visits and data collection\n* Eligibility for robotic surgery\n\nExclusion Criteria:\n\n* Unsuitability for anesthesia\n* Cognitive or psychiatric disorders affecting consent or compliance","ALL","18 Years",{"count":56,"type":57},250,"ESTIMATED","OBSERVATIONAL","A prospective observational study aimed at evaluating the feasibility, safety, and effectiveness of the Da Vinci SP robotic system for urologic procedures at IRCCS Candiolo. The study collects perioperative, oncologic, and functional outcomes, with exploratory comparisons to the multiport Da Vinci Xi system.",[61],"Urologic Surgical Procedure",[63,64,65],"Da Vinci Single Port (SP) System","Urologic Surgery","multiport","2025-06-13",{"date":68,"type":69},"2025-06-22","ACTUAL",{"date":71,"type":69},"2025-02-19",{"date":73,"type":57},"2031-12-31",{"name":5,"class":6},1]